Beta-Defensin 1 Genotype

Some people brush the same, floss the same, and see the dentist as often as their friends, and still get more cavities, more gum trouble, or more thrush. Part of the reason may be written in one small gene.

This test reads selected inherited variants in your DEFB1 gene from a saliva sample. Saliva is just the DNA source. The result is your inherited DNA pattern, not a changing saliva protein level.

DEFB1 carries instructions for beta-defensin 1. Beta-defensin 1 is a small protein used in the mouth's baseline defense against microbes. Some DEFB1 variants change how much of this protein appears in saliva. Others have only been linked to disease risk in association studies.

What DEFB1 Does in Your Mouth

Beta-defensin 1 is made by cells lining the gums, salivary glands, and other mouth tissues. It is mostly an always-on defense, present at a low baseline level rather than switching on sharply only after infection. It can damage bacterial and fungal membranes, and it helps call immune cells into the area.

The gene sits in the defensin cluster on chromosome 8, at band 8p23.1-8p23.2. Several studied variants are in the 5' untranslated region, the control region at the front of the gene. Change it and you may change how much beta-defensin 1 gets made in the saliva bathing your teeth and gums.

The Variants Covered Here

Four DEFB1 spots come up often in the oral-health research. Three sit in the 5' untranslated region: -52G>A (rs1799946), -44C>G (rs1800972), and -20G>A (rs11362). A fourth, rs1047031, sits in the 3' untranslated region, in a spot that microRNAs can bind.

Read the table as a map of what is known, not a score. Each variant may nudge risk for a different problem, and the pattern is more useful than any single letter.

Cavities

The caries signal is strongest for rs11362, but it is still not a clinical risk score. A 2020 meta-analysis found rs11362 associated with caries in permanent teeth; the same pattern was not seen in primary or mixed teeth. In an earlier U.S. study, carrying the variant allele at G-20A was linked to more than five-fold higher DMFT and DMFS scores, while the -52 G-52A variant tracked with lower DMFT in the same study. DMFT and DMFS are ways dentists count teeth or tooth surfaces affected by decay, fillings, or loss from decay.

Saliva data point in the same biological direction. In 678 Brazilian children, beta-defensin 1 in saliva was higher in cavity-free children, though DEFB1 variants themselves were not the main driver in that cohort. A microRNA variant (miRNA202) drove the peptide-level signal instead. Other Chinese, Italian, Turkish, and Brazilian cohorts have reported DEFB1 signals, but the exact risk allele is not identical across populations.

None of this overrides diet, fluoride, saliva flow, plaque, or sugar timing. It sets a starting slope. Two people with the same habits can end up in different places if one starts with weaker mouth-lining defense. The caries story is a modest inherited nudge, not a causal chain from genotype to disease.

Gum Disease

Periodontitis evidence is less clean than caries or Candida. Individual studies linked DEFB1 variants with chronic periodontitis in Japanese, Brazilian, and Italian groups. A meta-analysis of 18 case-control studies did not find a simple overall association for rs11362, rs1799946, or rs1800972, but did find subgroup signals by ancestry and disease type. So this is a risk modifier, not a diagnosis.

Persistent apical periodontitis is a root-tip infection that remains after root canal treatment. In 162 Brazilian patients, rs11362 was linked to lower risk and rs1799946 to higher risk, and the two variants interacted.

The protein level itself can move in different directions across gum diseases. Gingival beta-defensin 1 was lower in gingivitis and aggressive periodontitis but higher in chronic periodontitis. In another study, beta-defensin 1 was higher in the fluid at the gumline from people with periodontitis and type 2 diabetes.

Why Direction Is Not Simple

The tempting mistake is to label beta-defensin 1 as good when high and bad when low. It does not work that way. Low baseline production may leave the front line thinner. High levels in chronic inflammation can mean the tissue is already under pressure.

A DEFB1 result tells you about inherited starting conditions. It does not tell you whether your gums are inflamed today.

Oral Yeast (Candida)

The cleanest single-variant finding is -44C>G in oral Candida carriage. In a small study of 43 people with type 1 diabetes and 50 controls, carrying the G allele was linked to low Candida counts in saliva. In the diabetes group, G carriers were about 25 times more likely to fall into the low-carriage group; the control estimate pointed the same way, roughly eight-fold, but was much less certain.

Diabetes raised Candida carriage in that study, so this result matters most when diabetes, dry mouth, dentures, or inhaled steroids are already part of the picture.

Oral Lichen Planus and Mouth Ulcers

People with oral lichen planus had higher salivary beta-defensin 1 than controls in one Italian study, and their -52 and -44 genotypes tracked with those levels. The controls were younger, so this should not be used as a diagnostic clue.

For recurrent aphthous stomatitis, the overall genotype signal is weak. Male heterozygotes at -20 and -44 appeared more often than expected in one study, but the main analysis did not support DEFB1 as a broad canker-sore marker.

Behcet's Disease

DEFB1 has also been studied in Behcet's disease, a multisystem inflammatory disease where recurrent mouth ulcers are common. In one Tunisian study, the -20 GA and AA genotypes were linked to higher Behcet's disease risk, especially neurological involvement. That is adjacent to oral disease, but it does not turn this test into a Behcet's screen.

What the Best Meta-Analysis Found

A 2020 meta-analysis pooled 13 case-control studies across caries, periodontitis, oral lichen planus, and recurrent canker sores. Only rs1047031 reached statistical significance across all oral pathologies grouped together. The three promoter variants, rs11362, rs1800972, and rs1799946, did not survive pooling as broad oral-disease markers. The authors themselves flagged that even the rs1047031 signal rested on few studies and should be read cautiously.

That is the main limit of this test. The promoter variants may matter in narrower settings, such as -44C>G for Candida or rs11362 for caries in permanent teeth, but they are not broad yes-or-no markers for oral disease.

Why One Test, For Life

Your DEFB1 genotype does not change. You test once. The value is in using the answer when you plan dental care over time.

If you carry variants tied to higher cavity or gum risk, you might shorten recall intervals, use more aggressive fluoride and saliva-flow strategies, and have periodontal charting done earlier. If Candida susceptibility appears higher and you also have diabetes, dry mouth, dentures, or inhaled-steroid use, you watch for thrush sooner. The companion tests change over time; the genotype does not.

When the Result Can Mislead

A few things can make a fixed DNA result look more certain than it is.

• Panel coverage: this test reads selected known variants. A negative result only rules out those variants, not rare DEFB1 changes or other oral-immune genes.
• Strand and naming: papers may report the same variant with different letter labels because they read opposite DNA strands. Match the rs number first.
• Ancestry: DEFB1 allele frequencies vary between populations. Risk estimates from an Italian, Brazilian, Chinese, or Turkish cohort may not apply the same way to everyone.
• Small primary studies: several disease associations come from small cohorts. A single variant call rarely tells the whole story.
• Variants of uncertain significance: broad sequencing can find a DNA change that a lab cannot yet interpret. A targeted variant panel usually avoids this by reporting predefined variants, but it sees less.
• Clinical-grade versus direct-to-consumer data: raw consumer genotypes can be wrong or incomplete. Confirm a surprising result with a clinical-grade test before using it for family decisions.
• Somatic findings: this is a germline test. It is meant to read inherited DNA, not DNA changes found only in a tumor, inflamed tissue, or mouth lesion.
• Sample quality: saliva and buccal swabs should give the same inherited genotype as blood when enough cells are collected. A low-cell sample can fail or need repeat collection.
• Genotype is not phenotype: carrying a risk variant does not mean you will get the disease. Habits, medical conditions, saliva flow, oral bacteria, and dental care still do most of the work.

What to Do With a Higher-Risk Pattern

If your result points toward higher cavity risk, tighten the basics first: fluoride toothpaste twice a day, interdental cleaning, fewer sweet or acidic sipping windows, and earlier dental recalls. If cavities keep appearing, prescription-strength fluoride is a reasonable next step to raise with your dentist.

If it points toward higher gum disease risk, pocket-depth measurements matter. A periodontal pathogen panel can show which bacteria are present. hs-CRP can show whether inflammation extends beyond the mouth, but it does not diagnose periodontitis.

If it points toward higher Candida susceptibility and you have diabetes, dry mouth, dentures, or use an inhaled steroid, take mouth soreness or a white coating seriously. HbA1c is a useful companion marker because glucose control changes oral Candida risk.

If a result is surprising or would change decisions for children or siblings, confirm it with a clinical-grade assay. Most people do not need a genetic counselor for common DEFB1 variants. A counselor is more useful when broad sequencing finds rare or uncertain variants, or when a strong family pattern needs sorting out.

How to Read This Test

This is a research-grade marker, not a screening guideline. There is no expert panel telling everyone to get it, and no threshold that says treat. The dental steps it might prompt, fluoride, tighter recall intervals, pocket-depth monitoring, and HbA1c checks, are standard care that does not actually depend on knowing your DEFB1 genotype. It is most useful when oral health does not match effort, or when cavities, gum disease, or oral Candida show up across biological relatives. Read it as one input into a dental plan, not a verdict on your mouth.